From IPOdesktop's IPO preview: KIN is a development stage biopharmaceutical company focused on saving and improving the lives of pets ... KIN's lead product candidates are CereKin for the treatment of osteoarthritis pain and inflammation in dogs; AtoKin for the treatment of atopic dermatitis in dogs; and SentiKin for the treatment of post-operative pain in dogs."
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs